XML 27 R15.htm IDEA: XBRL DOCUMENT
v3.10.0.1

STOCK-BASED COMPENSATION | 9 Months Ended
--- | ---
Oct. 31, 2018
STOCK-BASED COMPENSATION |
STOCK-BASED COMPENSATION | NOTE 10 – STOCK-BASED COMPENSATION The Company’s board of directors may make awards under the 2011 Stock Plan (the “Stock Plan”) to officers, directors and key employees. Awards may include incentive stock options (“ISOs”), nonqualified stock options (“NSOs”), and restricted or unrestricted stock. All stock options awarded under the Stock Plan shall have an exercise price per share at least equal to the common stock’s market value per share at the date of grant. ISOs shall have a term no longer than ten years; NSOs may have up to a ten-year term. In the past, stock options typically became exercisable one year from the date of award. Commencing in January 2018, stock options were awarded with three-year vesting schedules. As of October 31, 2018, there were approximately 1.8 million shares of the Company’s common stock reserved for issuance under the Company’s stock plans. This number includes 675,500 shares of the Company’s common stock available for future awards. Summaries of stock option activity under the Company’s stock plans for the nine months ended October 31, 2018 and 2017, along with corresponding weighted average per share amounts, are presented below (shares in thousands):
|  |  |  | Exercise |  | Remaining |  |
|  | Shares |  | Price |  | Term (years) |  | Fair Value
Outstanding, February 1, 2018 |  | 889 |  | $ | 44.83 |  | 7.91 |  | $ | 11.74
Granted |  | 192 |  | $ | 40.32 |  |  |  |  |
Exercised |  | (3) |  | $ | 17.33 |  |  |  |  |
Outstanding, October 31, 2018 |  | 1,078 |  | $ | 44.11 |  | 7.63 |  | $ | 11.33
Exercisable, October 31, 2018 |  | 709 |  | $ | 44.57 |  | 6.69 |  | $ | 11.77
|  |  |  | Exercise |  | Remaining |  |
|  | Shares |  | Price |  | Term (years) |  | Fair Value
Outstanding, February 1, 2017 |  | 707 |  | $ | 39.04 |  | 7.82 |  | $ | 10.22
Granted |  | 125 |  | $ | 63.58 |  |  |  |  |
Exercised |  | (90) |  | $ | 30.74 |  |  |  |  |
Forfeited |  | (10) |  | $ | 71.75 |  |  |  |  |
Outstanding, October 31, 2017 |  | 732 |  | $ | 43.81 |  | 7.59 |  | $ | 11.61
Exercisable, October 31, 2017 |  | 452 |  | $ | 28.75 |  | 6.52 |  | $ | 7.76
The changes in the number of non-vested options to purchase shares of common stock for the nine months ended October 31, 2018 and 2017, and the weighted average fair value per share for each number, are presented below (shares in thousands):
|  | Shares |  | Fair Value
Non-vested, February 1, 2018 |  | 302 |  | $ | 13.55
Granted |  | 192 |  | $ | 9.35
Vested |  | (125) |  | $ | 16.19
Non-vested, October 31, 2018 |  | 369 |  | $ | 10.47
|  | Shares |  | Fair Value
Non-vested, February 1, 2017 |  | 270 |  | $ | 14.93
Granted |  | 125 |  | $ | 16.19
Vested |  | (105) |  | $ | 9.66
Forfeited |  | (10) |  | $ | 19.14
Non-vested, October 31, 2017 |  | 280 |  | $ | 17.83
In April 2018 and pursuant to terms of the Stock Plan, the Company awarded performance-based restricted stock units to two senior executives covering up to 36,000 shares of common stock plus a number of shares to be determined based on the amount of cash dividends deemed paid on shares earned pursuant to the awards. The release of the stock restrictions depends on the total shareholder return performance of the Company’s common stock measured against the performance of a peer-group of common stocks over a three-year period. Compensation expense related to stock awards was $0.3 million and $1.3 million for the three months ended October 31, 2018 and 2017, respectively, and was $1.2 million and $3.6 million for the nine months ended October 31, 2018 and 2017, respectively. At October 31, 2018, there was $3.6 million in unrecognized compensation cost related to outstanding stock awards that the Company expects to expense over the next three years. The total intrinsic value of the stock options exercised during the nine months ended October 31, 2018 and 2017, was $0.1 million and $3.1 million, respectively. At October 31, 2018, the aggregate market value amounts of the shares of common stock subject to outstanding and exercisable stock options, that were “in-the-money”, exceeded the aggregate exercise prices of such options by $7.1 million and $6.4 million, respectively. The Company estimates the weighted average fair value of stock options on the date of award using a Black-Scholes option pricing model, which was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. The Company believes that its stock option exercise activity is sufficient to provide it with a reasonable basis upon which to estimate the expected life of newly awarded stock options. The fair values of stock options granted during the periods presented below were estimated on the corresponding dates of award using the Black-Scholes option-pricing model based on the following weighted average assumptions:
|  | Nine Months Ended October 31, |
|  | 2018 |  | 2017 |
Dividend yield |  | 2.5 | % | 1.1 | %
Expected volatility |  | 35.0 | % | 36.0 | %
Risk-free interest rate |  | 2.4 | % | 1.6 | %
Expected life (in years) |  | 3.3 |  | 3.4 |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration